Synapse - Works

Results (2146)

Alisertib in combination with weekly paclitaxel in patients with advanced breast cancer or recurrent ovarian cancer: A randomized clinical trial

Journal Article

Falchook, G.; Coleman, R. L.; Roszak, A.; Behbakht, K.; Matulonis, U.; Ray-Coquard, I.; Sawrycki, P.; Duska, L. R.; Tew, W.; Ghamande, S.; more...
JAMA Oncology (2019)

Fulltext@MSK | Save

Comparison of outcomes in early-stage uterine clear cell carcinoma and serous carcinoma

Journal Article

Zhang, M.; Yang, T. J.; Desai, N. B.; DeLair, D.; Kollmeier, M. A.; Makker, V.; Leitao, M. M. Jr; Abu-Rustum, N. R.; Alektiar, K. M.
Brachytherapy (2019)

Fulltext@MSK | Save

Role of immunotherapy in the management of locally advanced and recurrent/metastatic cervical cancer

Guidelines

Dyer, B. A.; Zamarin, D.; Eskandar, R. N.; Mayadev, J. M.
Journal of the National Comprehensive Cancer Network (2019)

Fulltext@MSK | Save

Clinical trial experience with CA4P anticancer therapy: Focus on efficacy, cardiovascular adverse events, and hypertension management

Review

Grisham, R.; Ky, B.; Tewari, K. S.; Chaplin, D. J.; Walker, J.
Gynecologic Oncology Research and Practice (2018)

Fulltext@MSK | Save

PRECISE: A clinical-grade automated molecular eligibility screening and just-in-time (JIT) physician decision support solution for molecularly-selected oncology trials

Meeting Abstract

Tao, J.; Eubank, M. H.; Pamer, E.; Cangemi, N. A.; Drilon, A. E.; Harding, J. J.; Schram, A. M.; Smyth, L. M.; Jhaveri, K. L.; Li, B. T.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

A phase II evaluation of nivolumab, a fully human antibody against PD-1, in the treatment of persistent or recurrent cervical cancer

Meeting Abstract

Santin, A.; Deng, W.; Frumovitz, M. M.; Huh, W. K.; Khleif, S.; Lankes, H. A.; Ratner, E.; O'Cearbhaill, R.; Jazaeri, A. A.; Birrer, M.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Exploratory analysis of percentage of genomic loss of heterozygosity (LOH) in patients with platinum-sensitive recurrent ovarian carcinoma (rOC) in ARIEL3

Meeting Abstract

Oaknin, A.; Ledermann, J. A.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Dean, A. P.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

A phase I study of concomitant galinpepimut-s (GPS) in combination with nivolumab (nivo) in patients (pts) with WT1+ ovarian cancer (OC) in second or third remission

Meeting Abstract

O'Cearbhaill, R. E.; Gnjatic, S.; Aghajanian, C.; Iasonos, A.; Konner, J. A.; Losada, N.; Sarasohn, D.; Rasalan, T.; Tew, W. P.; Zamarin, D.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Baseline demographics and disparities in cancer registration trials: An analysis of US Food and Drug Administration approved drugs in 2015 and 2016

Meeting Abstract

Maniar, R.; Green, A.; Bach, P.; Mailankody, S.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Lenvatinib plus pembrolizumab in patients with renal cell carcinoma: Updated results

Meeting Abstract

Lee, C. H.; Makker, V.; Rasco, D. W.; Taylor, M. H.; Stepan, D. E.; Shumaker, R. C.; Schmidt, E. V.; Guo, M.; Dutcus, C. E.; Motzer, R. J.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save